Humanigen, Inc
HGENDelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001293310
Humanigen, Inc was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Oct 20, 2023; 38 institutions reported holding it in 13F filings for Q2 2023, worth $839.7K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Humanigen, Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 65 | 1 | 53 | −11 |
| Shares | 21.9M | 61.0K | 7.28M | −14.6M (−66.7%) |
| Value | $38.8M | $108.0K | $1.32M | −$37.4M (−96.6%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Humanigen, Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 865,700 | $156.0K | 0.00% |
| Advisors Management Group Inc | 100,000 | $18.0K | 0.01% |
| Virtu Financial LLC | 92,597 | $17.0K | 0.00% |
| Man Group plc | 87,586 | $16.0K | 0.00% |
| Simplex Trading, LLC | 73,995 | $13.0K | 0.00% |
| Captrust Financial Advisors | 61,000 | $11.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 43,575 | $8.00K | 0.00% |
| Two Sigma Securities, LLC | 39,030 | $7.00K | 0.00% |
| Wealth Alliance Advisory Group, LLC | 30,000 | $5.00K | 0.00% |
| Two Sigma Investments, LP | 20,201 | $4.00K | 0.00% |
| LMR Partners LLP | 17,406 | $3.00K | 0.00% |
| Bayesian Capital Management, LP | 18,400 | $3.00K | 0.00% |
| Triumph Capital Management | 17,000 | $3.00K | 0.00% |
| Commonwealth Equity Services, LLC | 10,690 | $1.00K | 0.00% |
Sold out (25)
Institutions that held Humanigen, Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Valiant Capital Management, L.P. | 6,888,607 | $12.2M |
| Murchinson Ltd. | 5,250,000 | $9.29M |
| Cowen and Company, LLC | 1,128,174 | $2.00M |
| Marshall Wace, LLP | 608,736 | $1.08M |
| D. E. Shaw & Co., Inc. | 352,853 | $624.0K |
| Charles Schwab Investment Management Inc | 262,756 | $466.0K |
| Ergoteles LLC | 239,900 | $425.0K |
| Goldman Sachs Group Inc | 215,900 | $382.0K |
| FMR LLC | 121,730 | $215.0K |
| XTX Topco Ltd | 116,882 | $207.0K |
| Occudo Quantitative Strategies LP | 113,359 | $201.0K |
| Schonfeld Strategic Advisors LLC | 85,100 | $151.0K |
| Legal & General Group Plc | 49,450 | $87.0K |
| HRT Financial LP | 37,340 | $66.0K |
| Graham Capital Management, L.P. | 36,940 | $65.0K |
| ExodusPoint Capital Management, LP | 32,171 | $57.0K |
| Boothbay Fund Management, LLC | 18,660 | $33.0K |
| Prudential Financial Inc | 17,400 | $31.0K |
| Two Sigma Advisers, LP | 11,700 | $21.0K |
| Walleye Capital LLC | 11,976 | $21.0K |
| O'Dell Group, LLC | 1,759 | $3.00K |
| New York State Common Retirement Fund | 342 | $1.00K |
| Barclays PLC | 88 | $0 |
| Credit Suisse AG | 26 | $0 |
| Capital Advisors, Ltd. LLC | 252 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Humanigen, Inc at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Frontier Wealth Management LLC | 61,000 | $108.0K |